Skip to content

Insider · CIK 0001555851

Adrian Rawcliffe

ceoofficerdirector

Files at ADAPY (Adaptimmune Therapeutics PLC), WVE (Wave Life Sciences Ltd.). First filing Jan 15, 2025, latest Dec 10, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $792k sold

Where the trades landed

Last year at the 2 companies this insider has traded most, with each buy and sell on the bar it happened.

WVE: Wave Life Sciences Ltd.

WVEOct 9, 2026 · close 3.46

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

ADAPY: Adaptimmune Therapeutics PLC

ADAPYOct 9, 2026 · close 0.03

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
35Weak
WVEsell 810b5-1
Wave Life Sciences Ltd.
$630k
42,000 shares
-77%+238% from low0% from high
25Weak
WVEsell10b5-1
Wave Life Sciences Ltd.
$109k
16,115 shares
-56%+22% from low-57% from high
50Moderate
ADAPYsell 5
Adaptimmune Therapeutics PLC
$18k
30,601 shares
-41%-
66Notable
ADAPYsell 5
Adaptimmune Therapeutics PLC
$35k
59,569 shares
-196%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Oct 5, 2026WVE
Wave Life Sciences Ltd.
AGrant or award
Common Stock
+10,700$0.00$010,7005 d ago
Oct 5, 2026WVE
Wave Life Sciences Ltd.
AGrant or award
Stock Option (right to buy)derivative
+64,000$0.00$064,0005 d ago
Dec 8, 2025WVE
Wave Life Sciences Ltd.
MOption exercise
Ordinary Shares10b5-1
+42,000$5.97$251k54,700Dec 10, 2025
Dec 8, 2025WVE
Wave Life Sciences Ltd.
SOpen-market sale
Ordinary Shares10b5-1
-42,000$15.00$630k12,700Dec 10, 2025
Dec 8, 2025WVE
Wave Life Sciences Ltd.
MOption exercise
Share Option (right to buy)derivative10b5-1
-42,000$0.00$00Dec 10, 2025
Nov 13, 2025WVE
Wave Life Sciences Ltd.
SOpen-market sale
Ordinary Shares10b5-1
-16,115$6.79$109k12,700Nov 14, 2025
Aug 11, 2025WVE
Wave Life Sciences Ltd.
AGrant or award
Ordinary Shares
+12,700$0.00$028,815Aug 13, 2025
Aug 11, 2025WVE
Wave Life Sciences Ltd.
AGrant or award
Share Option (right to buy)derivative
+76,200$0.00$076,200Aug 13, 2025
Feb 20, 2025ADAPY
Adaptimmune Therapeutics PLC
AGrant or award
Option to purchase Ordinary Sharesderivative
+5,143,248$0.00$05,143,248Feb 20, 2025
Feb 20, 2025ADAPY
Adaptimmune Therapeutics PLC
AGrant or award
Option to purchase Ordinary Sharesderivative
+3,428,832$0.00$03,428,832Feb 20, 2025
Jan 17, 2025ADAPY
Adaptimmune Therapeutics PLC
SOpen-market sale
American Depositary Shares representing Ordinary Shares
-30,601$0.58$18k44,327Jan 17, 2025
Jan 13, 2025ADAPY
Adaptimmune Therapeutics PLC
SOpen-market sale
American Depositary Shares representing Ordinary Shares
-12,539$0.59$7,37217,801Jan 15, 2025
Jan 13, 2025ADAPY
Adaptimmune Therapeutics PLC
SOpen-market sale
American Depositary Shares representing Ordinary Shares
-17,934$0.59$11k25,711Jan 15, 2025
Jan 15, 2025ADAPY
Adaptimmune Therapeutics PLC
SOpen-market sale
American Depositary Shares representing Ordinary Shares
-29,096$0.57$17k41,582Jan 15, 2025

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

Adrian Rawcliffe: insider trades and track record | InsiderTell